These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2857060)

  • 21. Prenalterol in cardiogenic shock following acute myocardial infarction.
    Coma-Canella I; Lopez-Sendon J; Jadraque LM
    Am Heart J; 1984 Jun; 107(6):1195-201. PubMed ID: 6144265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological studies with prenalterol.
    Weisswange A; Csapo G; Kalusche D; Keck M
    Acta Med Scand Suppl; 1982; 659():123-36. PubMed ID: 6127883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Long-term effect of a new beta-agonist prenalterol in patients with severe congestive heart failure (author's transl)].
    Lambertz H; Erbel R; Meyer J; Schweizer P; Effert S
    Z Kardiol; 1982 Jan; 71(2):65-74. PubMed ID: 6122313
    [No Abstract]   [Full Text] [Related]  

  • 25. Prenalterol in the treatment of orthostatic hypotension in Shy-Drager syndrome.
    Goovaerts J; Verfaillie C; Knockaert D; Fagard R; Fiocchi R; Amery A; Lijnen P
    Acta Cardiol; 1984; 39(2):147-55. PubMed ID: 6145274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basic pharmacological properties of prenalterol.
    Mattsson H; Hedberg A; Carlsson E
    Acta Med Scand Suppl; 1982; 659():9-37. PubMed ID: 6127902
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure.
    Currie PJ; Kelly MJ; Middlebrook K; Federman J; Sainsbury E; Ashley J; Pitt A
    Br Heart J; 1984 May; 51(5):530-8. PubMed ID: 6326784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of i.v. prenalterol in patients with severe cardiac failure at rest and during exercise.
    Doering W; Wauer B; Isbary J
    Acta Med Scand Suppl; 1982; 659():307-14. PubMed ID: 6127897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of prenaterol and cardiac glycosides in patients with recent myocardial infarction.
    Boström PA; Andersson J; Johansson BW; Lilja B; Thorell J; Tidfält K; Westerling S
    Eur J Clin Invest; 1984 Jun; 14(3):175-80. PubMed ID: 6147253
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prenalterol (Hyprenan). A new cardiotonic agent].
    Pelle H; Svendsen TL; Kampmann JP
    Ugeskr Laeger; 1982 Dec; 144(49):3688-90. PubMed ID: 6133384
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacodynamic effects of prenalterol in healthy subjects.
    Johnsson G
    Acta Med Scand Suppl; 1982; 659():109-22. PubMed ID: 6127882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hemodynamic assessment of prenalterol: a cardioselective beta agonist in patients with imparied left ventricular function.
    Klein W; Brandt D; Maurer E
    Clin Cardiol; 1981; 4(6):325-9. PubMed ID: 6120057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of prenalterol on dialysis-associated hypotension.
    Ladefoged J
    Eur J Clin Pharmacol; 1984; 26(3):399-400. PubMed ID: 6145594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of hypotension and bradycardia with prenalterol.
    Ostergaard D; Hüttemeier P; Pedersen T
    Anaesthesia; 1984 May; 39(5):494-5. PubMed ID: 6145369
    [No Abstract]   [Full Text] [Related]  

  • 35. Inotropic, chronotropic and dromotropic effects of prenalterol, a new cardiostimulant drug.
    Moore EN; Aberg G; Spear JF; Hodess AB; Herrmann I; Adler G
    Acta Med Scand Suppl; 1982; 659():53-70. PubMed ID: 6958179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The haemodynamic effects of intravenous prenalterol and ouabain in conscious dogs.
    Ek L; Björkman JA; Carlsson E; Johansson B
    Acta Med Scand Suppl; 1982; 659():39-52. PubMed ID: 6127899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular effects of prenalterol on rest and exercise haemodynamics in patients with chronic congestive cardiac failure.
    Tweddel AC; Murray RG; Pearson D; Martin W; Hutton I
    Br Heart J; 1982 Apr; 47(4):375-80. PubMed ID: 6121566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological and clinical effects of prenalterol--a new inotropic beta-adrenoceptor stimulant. Proceedings of a symposium in Hamburg, December 5, 1980.
    Acta Med Scand Suppl; 1982; 659():1-325. PubMed ID: 6127881
    [No Abstract]   [Full Text] [Related]  

  • 39. [Use of prenalterol in cardiogenic shock occurring in acute myocardial infarct].
    Coma-Canella I
    Ter Arkh; 1982; 54(11):104-5. PubMed ID: 6130619
    [No Abstract]   [Full Text] [Related]  

  • 40. Inotropic effect of prenalterol in amitriptyline poisoning.
    Heath A; Mårin P; Sjöstrand I
    Intensive Care Med; 1984; 10(4):209-11. PubMed ID: 6147367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.